GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.As of 25 May 2026, GKB OPHTHALMICS LTD. share price is ₹70.44. The stock opened at ₹68.00, compared to its previous close of ₹67.38. During today's trading session, GKB OPHTHALMICS LTD. share price moved in the range of ₹68.00 to ₹70.74, with an average price of ₹69.37 for the day. Looking at its last 52-week, the stock has touched a low of ₹68.00 and a high of ₹70.74.
The market capitalization of GKB OPHTHALMICS LTD. is ₹34 Crs, with a P/E ratio of -15.3 and a dividend yield of 0.00%.